Premenopausal Osteoporosis

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Seventh Edition

Volumn , Issue , 2009, Pages 289-293

  Cohen, Adi ^a   Shane, Elizabeth ^a  

^a Columhici University ^*  (United States)

Author keywords

Anorexia nervosa; Bisphosphonates; Cancer treatment; Fracture; Glucocorticoidinduced osteoporosis; HMD; Idiopathic osteoporosis; Lactation; Osteoporosis; Pregnancy; Premenopausal; Secondary causes; Teriparatide; Z score

Indexed keywords

EID: 77954693918     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470623992.ch63     Document Type: Chapter

References (41)

1. Thompson PW, Taylor J, Dawson A 2004 The annual incidence and seasonal variation of fractures of the distal radius in men and women over 25 years in Dorset, UK. Injury 35:462-166.
2. Wu F, Mason B, Home A, Ames R, Clearwater J, Liu M, Evans MC, Gamble GD, Reid IR 2002 Fractures between the ages of 20 and 50 vears increase women's risk of subsequent fractures. Arch Intern Med 162:33-36.
3. Hosmer WD. Genant HK, Browner WS 2002 Fractures before menopause: A red flag for physicians. Osteoporos Int 13:337-341.
4. Hui SL, Slemenda CW, Johnston CC Jr 1988 Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81:1804-1809.
5. Lewiecki EM 2005 Premenopausal bone health assessment. Curr Rheumatol Rep 7:46-52.
6. Kanis JA 2002 Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929-1936.
7. Lauder TD, Dixit S, Pezzin LE, Williams MV, Campbell CS, Davis GD 2000 The relation between stress fractures and bone mineral density: Evidence from active-duty Army women. Arch Phys Med Rehabil 81:73-79.
8. Lappe J, Davies K, Recker R, Heaney R 2005 Quantitative ultrasound: Use in screening for susceptibility to stress fractures in female army recruits. J Bone Miner Res 20:571-578.
9. Wigderowitz CA, Cunningham T, Rowley DI, Mole PA, Paterson CR 2003 Peripheral bone mineral density in patients with distal radial fractures. J Bone Joint Surg Br 85:423-425.
10. Hung LK. Wu HT, Leung PC, Qin L 2005 Low BMD is a risk factor for low-energy Colles' fractures in women before and after menopause. Clin Orthop 435:219-225.
11. Kumagai S, Kawano S, Atsumi T, Inokuma S, Okada Y. Kanai Y, Kaburaki J, Kameda H, Suwa A, Hagiyama H, Hirohata S, Makino H, Hashimoto H 2005 Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases. J Rheumatol 32:863-869.
12. Borba VZ, Matos PG, da Silva Viana PR, Fernandes A, Sato EI, Lazaretti-Castro M 2005 High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 14:529-533.
13. Honkanen R. Tuppurainen M, Kroger H, Alhava E, Puntila E 1997 Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures. Calcif Tissue Int 60:327-331.
14. Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ III 1994 Epidemiology and clinical features of osteoporosis in young individuals. Bone 15:551-555.
15. Moreira Kulak CA, Schussheim DH, McMahon DJ, Kurland E, Silverberg SJ, Siris ES, Bilezikian JP, Shane E 2000 Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pracl 6:296-304.
16. Peris P, Guanabens N, Martinez de Osaba MJ, Monegal A, Alvarez L. Pons F, Ros I, Cerda D, Munoz-Gomez J 2002 Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum 32:64-70.
17. Kulak CAM, Schussheim DH, McMahon DJ, Kurland E, Silverberg SJ, Siris ES, Bilezikian JPES 2000 Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract 6:296-304.
18. Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY 1995 Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 10:1218-1224.
19. Rubin MR. Schussheim DH, Kulak CA, Kurland ES, Rosen CI, Bilezikian JP, Shane E 2005 Idiopathic osteoporosis in premenopausal women. Osteoporos Int 16:526-533.
20. Donovan MA, Dempster D, Zhou H, McMahon DJ, Fleischer J, Shane E 2005 Low bone formation in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 90:3331-3336.
21. Cohen A, Recker RR, Guo XE, Zhang XH, Lappe J, Eisenberg HF, McMahon DJ, Shane E 2007 Abnormal trabecular microarchitecture and mechanical competence in premenopausal women with idiopathic osteoporosis (IOP) can be detected by high resolution peripheral quantitative computed tomography (HRpQCT). American Society for Bone and Mineral Research, 29th Annual Meeting, September 16-19, 2007, Honolulu, HI, USA.
22. Wallace BA, Cumming RG 2000 Systematic review of randomized trials of the effect of exercise on bone mass in pre-and postmenopausal women. Calcif Tissue Int 67:10-18.
23. Mein AL, Briffa NK, Dhaliwal SS, Price RI 2004 Lifestyle influences on 9-year changes in BMD in young women. J Bone Miner Res 19:1092-1098.
24. Peris P, Monegal A, Martinez MA, Moll C, Pons F, Guanabens N 2007 Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis. Clin Rheumatol 26:958-961.
25. Powles TJ, Hickish T, Kanis J A, Tidy A, Ashley S 1996 Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 14:78-84.
26. Patlas N, Golomb G. Yaffe P, Pinto T. Breuer E, Ornoy A 1999 Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 60:68-73.
27. Minsker DH, Manson JM, Peter CP 1993 Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol 121:217-223.
28. O'Sullivan SM, Grey AB, Singh R, Reid IR 2006 Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17:1008-1012.
29. Biswas PN, Wilton LV, Shakir SA 2003 Pharmacovigilance study of alendronate in England. Osteoporos Int 14:507-514.
30. Chan B, Zacharin M 2006 Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: A report of four cases. J Clin Endocrinol Metab 91:2017-2020.
31. Munns CF, Rauch F, Ward L, Glorieux FH 2004 Maternal and fetal outcome after long-term pamidronate treatment before conception: A report of two cases. J Bone Miner Res 19:1742-1745.
32. Nzeusseu Toukap A, Depresseux G, Devogelaer JP, Houssiau FA 2005 Oral pamidronate prevents high-dose glucocorticoid-induced lumbar spine bone loss in premenopausal connective tissue disease (mainly lupus) patients. Lupus 14:517-520.
33. Nakayamada S, Okada Y, Saito K, Tanaka Y 2004 Etidronate prevents high dose glucocorticoid induced bone loss in premenopausal individuals with systemic autoimmune diseases. J Rheumatol 31:163-166.
34. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-induced Osteoporosis 2001 Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 44:1496-1503.
35. Fuleihan Gel H, Salamoun M, Mourad YA, Chehal A, Salem Z, Mahfoud Z, Shamseddine A 2005 Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: A randomized controlled trial. J Clin Endocrinol Metab 90:3209-3214.
36. Delmas PD, Balena R, Confravreux E, Hardouin C, Hardy P, Bremond A 1997 Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: A double-blind, placebo-controlled study. J Clin Oncol 15:955-962.
37. Gnant MF, Mlineritsch B, Luschin-Ebengreuth G, Grampp S, Kaessmann H, Schmid M, Menzel C, Piswanger-Soelkner JC, Galid A, Mittlboeck M, Hausmaninger H. Jakesz R 2007 Zoled-ronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: A report from the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 25:820-828.
38. Golden NH, Iglesias EA, Jacobson MS, Carey D, Meyer W, Schebendach J, Hertz S, Shenker IR 2005 Alendronate for the treatment of osteopenia in anorexia nervosa: A randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 90:3179-3185.
39. Miller KK, Grieco KA, Mulder J, Grinspoon S, Mickley D, Ye-hezkel R. Herzog DB, Klibanski A 2004 Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 89:3903-3906.
40. Finkelstein JS. Klibanski A, Arnold AL, Toth TL, Hornstein MD, Neer RM 1998 Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(l-34): A randomized controlled trial. JAMA 280:1067-1073.
41. Taylor KA, Saag KG, Shane E, Boonen S, Donley DW, Marin F, Warner MR. Dalsky GP, Marcus R 2007 Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis The International Society for Clinical Densitometry, 13th Annual Meeting, March 14-17, 2007, Tampa, FL. USA.